Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel R Chamberlain

Showing results (21-30 of 348) with videos related to

Pageof 35
Sort By:
Neuropsychology Review|March 11, 2019
Efficacy of Pharmacological Interventions in Targeting Decision-Making Impairments across Substance and Behavioral AddictionsSamuel R Chamberlain, Jon E Grant
Psychiatry Research|May 18, 2018
Minnesota Impulse Disorders Interview (MIDI): Validation of a structured diagnostic clinical interview for impulse control disorders in an enriched community sampleSamuel R Chamberlain, Jon E Grant
Psychological Medicine|August 25, 2018
Selective role for the COMT polymorphism in a trans-diagnostic compulsivity phenotypeSamuel R Chamberlain, Jon E Grant
Addictive Behaviors|May 28, 2014
Impulsive action and impulsive choice across substance and behavioral addictions: cause or consequence?Jon E Grant, Samuel R Chamberlain
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|January 30, 2023
Does gambling differ in people with a minority sexual orientation?Jon E Grant, Samuel R Chamberlain
CNS Spectrums|September 11, 2023
Duration of untreated illness in gambling disorderJon E Grant, Samuel R Chamberlain
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2019
Gambling and substance use: Comorbidity and treatment implicationsJon E Grant, Samuel R Chamberlain
CNS Drugs|July 9, 2021
Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and EffectivelySamuel R Chamberlain, David S Baldwin
Psychiatry Research|May 13, 2018
Salivary sex hormones in adolescent females with trichotillomaniaJon E Grant, Samuel R Chamberlain
CNS Drugs|December 7, 2021
Authors' Reply to Ulrich: Comment on 'Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use Them Safely and Effectively'David S Baldwin, Samuel R Chamberlain
Pageof 35

Showing results (21-30 of 348) with videos related to

Sort By:
Pageof 35
Neuropsychology Review|March 11, 2019
Efficacy of Pharmacological Interventions in Targeting Decision-Making Impairments across Substance and Behavioral AddictionsSamuel R Chamberlain, Jon E Grant
Psychiatry Research|May 18, 2018
Minnesota Impulse Disorders Interview (MIDI): Validation of a structured diagnostic clinical interview for impulse control disorders in an enriched community sampleSamuel R Chamberlain, Jon E Grant
Psychological Medicine|August 25, 2018
Selective role for the COMT polymorphism in a trans-diagnostic compulsivity phenotypeSamuel R Chamberlain, Jon E Grant
Addictive Behaviors|May 28, 2014
Impulsive action and impulsive choice across substance and behavioral addictions: cause or consequence?Jon E Grant, Samuel R Chamberlain
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|January 30, 2023
Does gambling differ in people with a minority sexual orientation?Jon E Grant, Samuel R Chamberlain
CNS Spectrums|September 11, 2023
Duration of untreated illness in gambling disorderJon E Grant, Samuel R Chamberlain
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2019
Gambling and substance use: Comorbidity and treatment implicationsJon E Grant, Samuel R Chamberlain
CNS Drugs|July 9, 2021
Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and EffectivelySamuel R Chamberlain, David S Baldwin
Psychiatry Research|May 13, 2018
Salivary sex hormones in adolescent females with trichotillomaniaJon E Grant, Samuel R Chamberlain
CNS Drugs|December 7, 2021
Authors' Reply to Ulrich: Comment on 'Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use Them Safely and Effectively'David S Baldwin, Samuel R Chamberlain
Pageof 35